BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
2019
Purpose
BRCA1 and BRCA2 proteins are central to DNA repair process through homologous recombination. We hypothesize that BRCA1/BRCA2 mutation carriers may exhibit increased hematological toxicity when receiving genotoxic chemotherapy.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
7
Citations
NaN
KQI